Quince Therapeutics, Inc. (QNCX)
(Real Time Quote from BATS)
$1.69 USD
+0.03 (1.81%)
Updated Aug 7, 2025 03:54 PM ET
After-Market: $1.68 -0.01 (-0.59%) 4:14 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
QNCX 1.69 +0.03(1.81%)
Will QNCX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for QNCX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for QNCX
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for ...
QNCX: JMP Securities Initiates Coverage with Market Outperform Rating | QNCX Stock News
This Lionsgate Studios Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Quince Therapeutics (QNCX) Receives Positive Coverage with Strong Growth Potential
Quince Therapeutics initiated with an Outperform at Citizens JMP